1172623-96-9

Basic information

• Product Name: tert-butyl 1-(2,5-difluorophenyl)-1-oxopent-4-yn-2-ylcarbaMate
• Synonyms: tert-butyl 1-(2,5-difluorophenyl)-1-oxopent-4-yn-2-ylcarbaMate;tert-Butyl [1-(2,5-difluorophenyl)-1-oxo-4-pentyn-2-yl]carbamate;Carbamic acid, N-[1-(2,5-difluorobenzoyl)-3-butyn-1-yl]-, 1,1-dimethylethyl ester
• CAS NO: 1172623-96-9
• Molecular Formula: C₁₆H₁₇F₂NO₃
• Molecular Weight: 309.3078864
• Mol File: 1172623-96-9.mol
• Article Data: 17

Chemical Properties

• Boiling Point: 429.7±45.0 °C(Predicted)
• Appearance: /
• Density: 1.199±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 10.20±0.46(Predicted)
• CAS DataBase Reference: tert-butyl 1-(2,5-difluorophenyl)-1-oxopent-4-yn-2-ylcarbaMate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 1-(2,5-difluorophenyl)-1-oxopent-4-yn-2-ylcarbaMate(1172623-96-9)
• EPA Substance Registry System: tert-butyl 1-(2,5-difluorophenyl)-1-oxopent-4-yn-2-ylcarbaMate(1172623-96-9)

Safety Data

• Hazardous Substances Data: 1172623-96-9(Hazardous Substances Data)

Usage

Description

tert-butyl 1-(2,5-difluorophenyl)-1-oxopent-4-yn-2-ylcarbaMate is a complex organic compound characterized by its unique molecular structure. It is a carbamate derivative with a 2,5-difluorophenyl group and a 1-oxopent-4-yn-2-yl moiety, which contributes to its reactivity and potential applications in various chemical and pharmaceutical processes.

Uses

Used in Pharmaceutical Industry:
tert-butyl 1-(2,5-difluorophenyl)-1-oxopent-4-yn-2-ylcarbaMate is used as a reactant for the preparation of a highly functionalized tetrahydropyran DPP-4 inhibitor. DPP-4 inhibitors are a class of drugs that play a crucial role in the treatment of type 2 diabetes by regulating blood glucose levels. The compound's unique structure allows it to be a key intermediate in the synthesis of these therapeutic agents, contributing to the development of more effective and safer treatments for diabetes patients.

Upstream product

• 1172623-95-8 (±)-tert-butyl (1-(methoxy(methyl)amino)-1-oxopent-4-yn-2-yl)carbamate 
• 899819-34-2 (2,5-difluorophenyl)magnesium bromide 
• 24424-99-5 di-tert-butyl dicarbonate 
• 6165-75-9 propargyl benzenesulfonate 
• 106-96-7 propargyl bromide 
• 540-36-3 para-difluorobenzene 
• 60468-36-2 α-chloro-2',5'-difluoroacetophenone 
• 167904-79-2 methyl (R,S)-2-(N-diphenylmethylidene)aminopent-4-ynoate 
• 100860-41-1 ethyl 2-aminopent-4-ynoate 
• 171922-16-0 ethyl 2-[(diphenylmethylidene)amino]pent-4-ynoate 
• 61172-66-5 2-((tert-butoxycarbonyl)amino)pent-4-ynoic acid 
• 50428-03-0 D,L-propargylglycine 
• 399-94-0 2-bromo-1,4-difluorobenzene 

Downstream Products

• 1172623-98-1 tert-butyl [(2R,3S)-2-(2,5-difluorophenyl)-3,4-dihydro-2H-pyran-3-yl]carbamate 
• 1172623-99-2 tert-butyl [(2R,3S)-2-(2,5-difluorophenyl)-5-hydroxytetrahydro-2H-pyran-3-yl]carbamate 
• 951127-25-6 N-[(2R,3S)-2-(2,5-difluorophenyl)tetrahydro-5-oxo-2H-pyran-3-yl]carbamic acid 1,1-dimethylethyl ester 

Relevant articles and documents

Ternary fused ring substituted six-membered ring derivatives and their use in medicine

The invention relates to a fused tricyclic substituted amino six-membered ring derivative and application thereof in medicine, particularly a fused tricyclic substituted amino six-membered ring derivative shown in a formula (I) or stereoisomers and pharmaceutically acceptable salts or pro-drugs of the derivative, a pharmaceutical composition comprising the derivative and use of the derivative in preparing a dipeptidyl peptidase IV (DPP-IV) inhibitor in medicine, wherein the substituents in the formula (I) are defined as in the description. The formula (I) is shown in the description.

AMINO PYRANOID RING DERIVATIVE AND COMPOSITION AND USE THEREOF

The present invention relates to an amino pyran ring derivative and a composition and use thereof, and in particular, to an amino pyran ring derivative represented by general formula (I) or a stereoisomer, a pharmaceutically acceptable salt or a prodrug thereof, a pharmaceutical composition comprising the derivative, and their medical use in the manufacture of a di-peptidyl peptidase IV (DPP-IV) inhibitor, in formula (I) the substituents are defined the same as those in the specification.

Amino 6-membered ring derivative and pharmaceutical applications thereof including the use for manufacturing dipeptidyl peptidase-4(IDPP-IV) inhibitor

The present invention relates to an amino 6-membered ring derivative and pharmaceutical applications thereof, which specifically relates to the amino 6-membered ring derivative represented by the general formula (I) or stereoisomers thereof, pharmaceutically acceptable salts thereof, a prodrug, a pharmaceutical composition comprising the derivative, and the pharmaceutical use for manufacturing dipeptidyl peptidase-4(IDPP-IV) inhibitor, wherein the definition of each substituent in the general formula (I) is the same as described in the specification.